Accurate Cell Counting Methods for CAR T Therapy

From Discovery to Manufacturing

CAR T Therapy

Accurate Cell Counting Methods, Fit for Purpose, for CAR T Therapy

CAR T Research Development Manufacturing
cell counters for CAR T development
Cellometer simple workflow for CAR T

“Our Cellometer Auto 2000 has greatly improved the speed and accuracy of our cell counting and has allowed us to analyze our cell samples in a variety of ways. The AOPI feature has been integral in generating cell viable data for a few of our new projects. The customer service team is also amazing! They are very knowledgeable about their products and technology and are always available to help us troubleshoot.”

NIH-NIDCD

“The Cellometer Auto 2000 and the AO/PI Viastain gives us the ability to get an accurate count of our live splenocytes while excluding the red blood cells.”

Eli Lilly

“…definitely the standard for cell counting. Results are consistent time and again, the reliability is great when performing duplicate or triplicate counts…. I also enjoy the ability to establish several different settings based on the type of cell, and appreciate Nexcelom’s customer service!”

Cold Spring Harbor Laboratory

RESEARCH

DEVELOPMENT

MANUFACTURING

“The Cellometer Auto 2000 has greatly aided the development of our tissue dissociation assays. The unit allows fast quantification of viable white blood cells from a heterogeneous population following spleen, thymus, lymph node, etc. dissolution which can then quickly proceed to downstream flow-based analysis. The time saved by this method has been extremely valuable!”

Takeda Pharmaceuticals
Accurate Counting for Primary Samples
Ezeh PC, et al. PLoS One. 2014; 9(4):e93920 | Xu H, et al. Toxicol Lett. 2016; 262:55-61

RESEARCH

DEVELOPMENT

MANUFACTURING

“We use the Cellometer Auto 2000 daily to count cells and assess viability of cells derived from a variety of sources. [We] perform a lot of cell line work, and need accurate counts and viability assessments before using the cells in downstream assays”

Regeneron Pharmaceuticals
Morphology Variability in Cancer Cell Lines
  • Cell counters need to handle NCI-60 cancer cell lines, of which 57% are clumpy, clustering, contain debris or have large variations in morphology.

Rothenberg SM, et al. Cancer Res. 2010; 70(6): 2158-64

RESEARCH

DEVELOPMENT

MANUFACTURING

CAR T development process
Singh H, et al. PLoS One. 2013; 8(5): e64138 | Wang X, et al. Cancer Gene Ther 2015; 22(2):85-94

RESEARCH

DEVELOPMENT

MANUFACTURING

“The Cellometer Auto 2000 has made functional testing of T cells a much quicker and simpler process than before! When the cell concentration of each population in a 96 well plate must be determined, it is hard to imagine having to count the cells by hand and doing this in a timely manner. Great product!” 

University of Texas at Austin
Optimized Viral Vector Development with Image Cytometer
White KM, et al. ACS Infectious Diseases 2018; 4(2):146-157 | Zhang Z, et al. BMC Biotechnology 2018; 18(1):4

RESEARCH

DEVELOPMENT

MANUFACTURING

“…We routinely process PBMCs from both fresh whole blood and from frozen stock. The Cellometer [Auto2000] has made it much easier to get cell numbers and viability percentages for use in downstream applications …” 

Human Longevity, Inc
Accurate Cell Counting Assay of Apheresis Materials – Suitable for Stability Program
  • Manual / trypan blue method is not accurate for counting leukapheresis. RBCs are 3-12x the number of lymphocytes.

  • Proven Repeatability: 14 PBMC samples were tested using the Cellometer Auto 2000. The resulting in a CV of < 6%.

Burchiel SW, et al. Inhal Toxicol. 2016; 28(2):61-70

RESEARCH

DEVELOPMENT

MANUFACTURING

Cell Counting Method Development Process
Cellometer Cell Counting | ♦ Celigo Imaging Cytometer

Critical Quality Attributes

Safety

  • Gram stain/sterility
  • Mycoplasma
  • Endotoxin level
  • Copies of transgene insertion
  • Replication Competent Retrovirus/Lentivirus 

Purity

  • % CD3+ T cells 
  • %CAR T cells 
  • Residual tumor burden
  • Residual beads

Identity

  • % CAR T cells 

Potency

  • In vitro Cytotoxic T Lymphocyte 
  • Interferon-γ secretion 

Critical Process Parameters

  • Cell growth and expansion 
  • Selection of target cells
  • Pre-stimulation conditions
  • Transduction conditions 

Stability

  • Shipping/Handling: Cryopreserved CAR T 
  • Storage validation for Apheresis materials: Fresh/Frozen/Thawed CAR T samples 
  • Vector
  • Final product
  • ≥70% cell viability is recommended for pre-clinical safety studies and clinical dose.

  • Cellometer K2 can measure cell viability from 0% viable to 100% viable cell population.

“I am currently using the Cellometer K2 in our lab, mostly to count T cells, PBMCs, and tumor cells. I use them for cell culture, and later the cells are used for further assays like ELISA and FACS. The instrument is very accurate, especially with AO/PI.”

EMD Serono

Cellometer K2 Linearity Measurement

Cellometer K2 Linearity Measurement
  • Accuracy translates from cell lines to primary samples.

Intermediate Precision: Instrument Repeatability and Validation

Intermediate Precision: Instrument Repeatability and Validation
  • Cellometer cell counters have been facilitating CAR T manufacturing with accurate cell counting and analysis since 2010.

Precision: Repeatability of Cellometer K2

Precision: Repeatability of Cellometer K2
Jin J, et al. J of Transl Med 2018; 16(1):13 | Singh H, et al. Cancer Gene Ther. (2015) 22(2):95-100 Manuri, PVR, et al. Human Gene Therapy.  2010; 21:427-437